:Butynamine

{{Short description|Chemical compound}}

{{Drugbox

| IUPAC_name = N-tert-Butyl-N,2-dimethylbut-3-yn-2-amine

| image = butynamine.png

| alt = Skeletal formula

| width = 180

| image2 = Butynamine-3D-balls.png

| alt2 = Ball-and-stick model

| tradename =

| pregnancy_category =

| legal_status =

| routes_of_administration =

| bioavailability =

| metabolism =

| elimination_half-life =

| excretion =

| CAS_number = 3735-65-7

| ATC_prefix = none

| ATC_suffix =

| ChEMBL = 2104389

| PubChem = 189910

| ChemSpiderID = 164936

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = 313QE5199Z

| C=10 | H=19 | N=1

| smiles = CC(C)(C)N(C)C(C)(C)C#C

| StdInChI=1S/C10H19N/c1-8-10(5,6)11(7)9(2,3)4/h1H,2-7H3

| StdInChIKey = PAVORIOUUILGMQ-UHFFFAOYSA-N

}}

Butynamine is a tertiary (a highly hindered) aliphatic amine which has antihypertensive effects.{{cite journal |vauthors=BREST AN, ONESTI G, SWARTZ C, BERLINER H, MOYER JH | title = Butynamine hydrochloride as an antihypertensive agent | journal = Current Therapeutic Research, Clinical and Experimental | volume = 4 | pages = 313–6 |date=June 1962 | pmid = 13872883 }}